+ Direct Access

HOT TOPIC RESULTS ~ SUPERNOVA PILOT TRIAL

(icTV) Interview with Alain Combes Is it possible and safe to deliver “super-protective” ventilatory strategies integrated by ECCO2R in patients with ARDS? To answer this question, the ESICM Trials Group conducted the SUPERNOVA study, a pilot multicentre international trial. Alain Combes (Paris, France) talks about preliminary results that he presented alongside Marco Ranieri (Rome, Italy) […]

Read More…

THANK YOU FROM LIVES 2017!

It was an amazing five days! In this icTV video, President Massimo Antonelli and Chair of Scientific Affairs Maurizio Cecconi thank participants, faculty and industry partners for their contributions to a very successful 30th annual congress in Vienna, and invite all to LIVES 2018 next October in Paris. […]

Read More…

HOT TOPIC RESULTS ~ EGDT FOR SEPSIS CARE IN ZAMBIA

(icTV) Interview with Todd Rice Does protocolised resuscitation with intravenous fluids, vasopressors, and blood transfusion implemented early after presentation to the emergency department improve in-hospital mortality among African adults with sepsis and hypotension compared with usual care? Todd Rice (Nashville, United States) describes the clinical impact of the results of this randomised clinical trial which […]

Read More…

(icTV) CLINICAL TRIAL RESULTS ~ Can rest after SBT reduce reintubation?

CLINICAL TRIAL RESULTS Can rest after SBT reduce reintubation? In this icTV interview, Maria del Mar Fernandez discusses results from her RCT “Reconnection to mechanical ventilation for one hour after a successful spontaneous breathing trial reduces reintubation in critically ill patients” presented during the Clinical Trials Session on Tuesday September 26th, 2017 at LIVES 2017 in […]

Read More…

RESULTS FROM THE BIGGEST NEW TRIALS

HOT TOPICS SESSION Wednesday September 27th, 14:10~17:20 #LIVES2017 Twitter Chairs: Stephen Shepherd, London, United Kingdom Richard Siviter, Reading, United Kingdom      This year our Hot Topics Session is hotter than ever! This highly anticipated session is jam packed with a record EIGHT scientific trials which will be presented publicly for the first time, with simultaneous publications […]

Read More…